Corrigendum to “clinical Outcomes of Black Vs. Non-Black Patients with Locally Advanced Non–small Cell Lung Cancer” [lung Cancer 114, (december 2017) 44–49]

The authors regret that Charles B. Simone II’s name appeared incorrectly in the original article. It appears correctly above./> The authors would like to apologise for any inconvenience caused. Clinical outcomes of black vs. non-black patients with locally advanced non–small cell lung cancerLung CancerVol. 114PreviewLung cancer remains the leading cause of cancer death in the United States (US) and worldwide [1]. Non–small cell lung cancer (NSCLC) accounts for 80% of the lung cancer diagnoses in the US and a quarter of patients present with locally advanced disease [2]. The non-Hispanic black population comprises about 12% of the US population, and while black patients experience a higher incidence and mortality rate of lung cancer [3], they remain underrepresented in prospective randomized clinical trials [4–6]. Full-Text PDF